188 related articles for article (PubMed ID: 18094516)
21. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.
Passaro A; Vigna GB; Romani A; Sanz JM; Cavicchio C; Bonaccorsi G; Valacchi G; Cervellati C
Oxid Med Cell Longev; 2018; 2018():1752940. PubMed ID: 30524650
[TBL] [Abstract][Full Text] [Related]
22. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
23. Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.
Rosenson RS
Am Heart J; 2008 Mar; 155(3):499.e9-16. PubMed ID: 18294485
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein-associated phospholipase A
Garg PK; Norby FL; Polfus LM; Boerwinkle E; Gibbs RA; Grove ML; Folsom AR; Garimella PS; Matsushita K; Hoogeveen RC; Ballantyne CM
Atherosclerosis; 2018 Jan; 268():12-18. PubMed ID: 29169030
[TBL] [Abstract][Full Text] [Related]
25. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina.
Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913
[TBL] [Abstract][Full Text] [Related]
26. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
Zhang H; Gao Y; Wu D; Zhang D
BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
[TBL] [Abstract][Full Text] [Related]
27. Association of 25-hydroxyvitamin D, lipoprotein-associated phospholipase A2 and asymptomatic coronary artery disease in patients with type 2 diabetes mellitus.
Zhang Q; Zhang QQ; He JJ; Dong SQ; Lu Y
Diabetes Res Clin Pract; 2024 Jun; 212():111681. PubMed ID: 38677367
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.
Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D
Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415
[TBL] [Abstract][Full Text] [Related]
29. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
[TBL] [Abstract][Full Text] [Related]
30. Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.
Maiolino G; Pedon L; Cesari M; Frigo AC; Wolfert RL; Barisa M; Pagliani L; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
PLoS One; 2012; 7(10):e48171. PubMed ID: 23118945
[TBL] [Abstract][Full Text] [Related]
31. Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.
Raichlin E; McConnell JP; Bae JH; Kremers WK; Lerman A; Frantz RP
Transplantation; 2008 Apr; 85(7):963-8. PubMed ID: 18408575
[TBL] [Abstract][Full Text] [Related]
32. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein-Associated Phospholipase A
Ntzouvani A; Giannopoulou E; Fragopoulou E; Nomikos T; Antonopoulou S
Lipids; 2019 Oct; 54(10):629-640. PubMed ID: 31489677
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
[TBL] [Abstract][Full Text] [Related]
34. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
Cai A; Li G; Chen J; Li X; Li L; Zhou Y
BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
[TBL] [Abstract][Full Text] [Related]
35. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study.
Brilakis ES; Khera A; Saeed B; Banerjee S; McGuire DK; Murphy SA; de Lemos JA
Clin Chem; 2008 Dec; 54(12):1975-81. PubMed ID: 18832472
[TBL] [Abstract][Full Text] [Related]
36. Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid-Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease.
Le NA; Tomassini JE; Tershakovec AM; Neff DR; Wilson PW
J Am Heart Assoc; 2015 Oct; 4(10):e001675. PubMed ID: 26486166
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective study.
Folsom AR; Lutsey PL; Roetker NS; Ballantyne CM; Hoogeveen RC; Rosamond WD; Cushman M;
Thromb Res; 2013 Jul; 132(1):44-6. PubMed ID: 23746626
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein-associated phospholipase A2 levels are associated with erectile dysfunction in patients without known coronary artery disease.
Otunctemur A; Sahin S; Ozbek E; Cekmen M; İnal A; Tulubas F; Dursun M; Besiroglu H; Koklu I
Andrologia; 2015 Aug; 47(6):706-10. PubMed ID: 25091174
[TBL] [Abstract][Full Text] [Related]
39. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
40. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.
Garg PK; Arnold AM; Hinckley Stukovsky KD; Koro C; Jenny NS; Mukamal KJ; Criqui MH; Furberg CD; Newman AB; Cushman M
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):750-6. PubMed ID: 26848158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
